Karl Landert
Angel Investor
Zürich, Switzerland
Karl Landert is a seed investor in Zürich focused on Medical and Health Care. Karl is the CEO and investor in eClinicalHealth, as well as the Chairman of the Board and an advisor to Clinpal and key customers. Karl’s career started at IBM in 1985. He was the founder of the IBM ClinWare Solution Unit, one of the first EDC systems for clinical trials in the mid-nineties. Between 1998 and 2001 he worked at Novartis as ChiefInformation Officer. His career continued at Credit Suisse, where he assumed several senior leadership positions in IT. He became CIO of the Group in 2008 and was a Member of the Executive Board of Credit-Suisse until 2012. In his functions at Credit-Suisse he oversaw hundreds of global change programs. In 2012 and 2013 Karl advised the Chairman of Credit-Suisse in setting up an innovation program for the firm. After retiring from Credit-Suisse in March 2013 Karl focused on a portfolio of investments in start-up companies, continues to advise Senior Leaders and is a Non-Executive director in technology companies. As of November 2015 Karl has taken on the role of CEO and dedicates his energy to eClinicalHealth where he defines and manages the direction of the company.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Karl Landert invests in
Stages Karl Landert invests in
Countries Karl Landert invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (100%)
- Health Care 2 (100%)
- Software 1 (50%)
- Clinical Trials 1 (50%)
- Information Technology 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Country
- Switzerland 1 (50%)
- United Kingdom 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| eClinicalHealth are a technology and consulting company providing solutions for the clinical trials industry. The company has developed a technology solution called Clinpal: Clinpal is a patient-centric, cloud-enabled platform that improves patient engagement and data acquisition through every step of the clinical trial journey. Clinpal allowsclinical trials get closer to the patient, improving trial efficiency, patient retention and helps capture high quality data in real time. The platform features a comprehensive workflow and communication engine for all stakeholders, including sites, patients CRAs and sponsors, which improves efficiency through the trial lifecycle. Clinpal’s data exchange capabilities enable the platform to act as an intelligent data hub, consolidating and enhancing biometric data with eSource reported directly by patients or clinicians. The scalable cloud architecture, automated configuration and flexible licensing models make these capabilities a viable choice across a wide range of clinical trials. | $2.8M / Series B / Sep 11, 2014 | ||
| Medical Insight's mission is to create an open medical community platform which serves Health Care Professionals (HCP) of various specialties, international medical foundations and its medical industry partners with targeted personalized knowledge, education and communication services. | Seed / Jul 02, 2013 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Karl Landert invest in?
Karl Landert invests primarily in Medical, Health Care and Software startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Karl Landert?
Public channels for Karl Landert include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Karl Landert last invest?
The most recent investment recorded for Karl Landert closed in Sep 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
